Healthcare Packaging -- Defined by the U.S. Food & Drug Administration as some combination of a drug, device, and/or biologic intended to be used together, combination products are often provided as one unit for simplicity and ease of use. The market for combination products is significant, and growing rapidly. According to the MarketsandMarkets report “Drug-Device Combination (2009-2014),” “The market for drug-device combination [products] was over $9 billion in 2008 and is expected to grow at a double-digit CAGR in the next few years.”